A third dose of SARS-CoV-2 vaccine increases neutralizing antibodies against variants of concern in solid organ transplant recipientsAndrew H. Karaba, William A. Werbel, Xianming Zhu et al.|American Journal of Transplantation|2021Cited by 103
Systemic Delivery of scAAV8-Encoded MiR-29a Ameliorates Hepatic Fibrosis in Carbon Tetrachloride-Treated MiceMatthew Knabel, Daniel Warren|PLoS ONE|2015Cited by 41
Calpain 9 as a therapeutic target in TGFβ-induced mesenchymal transition and fibrosisDavid H. Kim, Harry C. Dietz, James D. Beckett et al.|Science Translational Medicine|2019Cited by 38
Improved Antibody Response After a Fifth Dose of a SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Case SeriesAura T. Abedon, William A. Werbel, Mayan Teles et al.|Transplantation|2022Cited by 37
A Third Dose of SARS-CoV-2 Vaccine Increases Neutralizing Antibodies Against Variants of Concern in Solid Organ Transplant RecipientsAndrew H. Karaba, William A. Werbel, Joel N. Blankson et al.|medRxiv|2021Cited by 33